1. Home
  2. Labeler Index
  3. Genentech, Inc.
  4. 50242-554
  5. NDC Package Code: 50242-554-01 Ocrevus Zunovo

NDC Package 50242-554-01 Ocrevus Zunovo

Ocrelizumab And Hyaluronidase Injection, Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
50242-554-01
Package Description:
1 VIAL, SINGLE-USE in 1 CARTON / 23 mL in 1 VIAL, SINGLE-USE
Product Code:
50242-554
Proprietary Name:
Ocrevus Zunovo
Non-Proprietary Name:
Ocrelizumab And Hyaluronidase
Substance Name:
Hyaluronidase (human Recombinant); Ocrelizumab
Usage Information:
OCREVUS ZUNOVO is indicated for the treatment of:Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adultsPrimary progressive MS, in adults
11-Digit NDC Billing Format:
50242055401
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 2693458 - ocrelizumab-ocsq 920 MG / hyaluronidase-ocsq 23,000 UNT in 23 ML Injection
  • RxCUI: 2693458 - 23 ML hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML Injection
  • RxCUI: 2693458 - ocrelizumab-hyaluronidase-ocsq 920 MG / 23,000 UNT per 23 ML Injection
  • RxCUI: 2693458 - ocrelizumab-ocsq 920 MG / hyaluronidase-ocsq 23,000 UNT per 23 ML Injection
  • RxCUI: 2693465 - Ocrevus Zunovo 920 MG / 23,000 UNT in 23 ML Injection
Product Type:
Human Prescription Drug
Labeler Name:
Genentech, Inc.
Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route(s):
Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s):
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
BLA761371
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
09-13-2024
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

NDC HCPCS Crosswalk

This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

NDC 50242-554-01 HCPCS crosswalk information with package details and bill units information.

NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
50242055401J2351Inj ocrelizumab 1mg hya-ocsq1 MG231920920

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
50242-554-861 VIAL, SINGLE-USE in 1 CARTON / 23 mL in 1 VIAL, SINGLE-USE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 50242-554-01?

The NDC Packaged Code 50242-554-01 is assigned to a package of 1 vial, single-use in 1 carton / 23 ml in 1 vial, single-use of Ocrevus Zunovo, a human prescription drug labeled by Genentech, Inc.. The product's dosage form is injection, solution and is administered via subcutaneous form.

Is NDC 50242-554 included in the NDC Directory?

Yes, Ocrevus Zunovo with product code 50242-554 is active and included in the NDC Directory. The product was first marketed by Genentech, Inc. on September 13, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 50242-554-01?

The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

What is the 11-digit format for NDC 50242-554-01?

The 11-digit format is 50242055401. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-250242-554-015-4-250242-0554-01